Center for Dietary Supplements and Inflammation (CDSI) COBRE
Project Number1P30GM154631-01
Contact PI/Project LeaderNAGARKATTI, PRAKASH S Other PIs
Awardee OrganizationUNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
Description
Abstract Text
Overall Abstract
The Center for Dietary Supplements and Inflammation (CDSI) COBRE is located at the School of Medicine
(SOM), the University of South Carolina (USC), Columbia, SC. SOM is one of the smallest medical schools in
the nation located at the Veterans Administration (VA) campus. Thus, the CDSI attracts users from multiple
colleges across USC. The scientific mission of the CDSI is to investigate how compounds derived from
botanicals and natural products can attenuate inflammation as well as understand the mechanisms that trigger
chronic inflammatory diseases. Inflammation plays a critical role in the pathogenesis of not only autoimmune
diseases but also a wide range of clinical disorders including cardiovascular diseases, neurodegenerative
disorders, obesity, aging, and cancer. Thus, understanding the mode of action of botanicals or their constituents
on inflammation could lead to novel treatment modalities with far-ranging clinical implications. To accomplish
this goal, we will continue to build on the success of COBRE Phase-1 and Phase-2, further advance the research
infrastructure, grow the critical mass of researchers using diverse perspectives, and promote the sustainability
of the research cores. In Phases-1 and 2, we have made outstanding progress in the successful transition of 12
of our junior faculty Research Project Leaders (RPLs) into independent NIH/NSF-funded investigators as PIs.
Additionally, the CDSI funded 26 Pilot Project leaders (PPLs) who were also highly productive. Also, we were
successful in securing NIH Complementary and Alternative Medicine (CAM) Center (PPG/P01) for Epigenetic
Regulation of Inflammation, in which ‘graduated’ RPLs served as project leaders, thereby paving the path
towards sustainability of CDSI. The Specific Aims include: 1) To support innovative research using the latest
technologies and equipment such as Spectral Flow Cytometry, Single-cell RNA-seq and Single-cell Spatial
Transcriptomics, natural product library, and high-throughput data analysis, offered at our core facilities. 2) To
continue to grow the critical mass of researchers at CDSI by providing support through the Pilot Project Program
(PPP) and recruitment of new and early-stage as well as diverse investigators. 3) To sustain a multi-disciplinary,
collaborative research program and cores beyond Phase-3. The CDSI will offer two state-of-the-art research
core facilities that include a Flow Cytometry, and Cell Analysis (FCCA) Core, and a Bioanalytical Core, to study
epigenetic and microbiome regulation of inflammation. The program will be evaluated by an Administrative Core
(AC) consisting of nationally recognized scientists. Additionally, through institutional support, several new tenure-
track and diverse faculty will be recruited and mentored at USC to further increase the critical mass of users.
The long-term objective of the CDSI is to build a self-sustaining, nationally and internationally recognized multi-
disciplinary Center for dietary supplements and inflammation research.
Public Health Relevance Statement
Project Narrative
Inflammation is the underlying cause of a larger number of clinical disorders. Our Center will pursue multi-
disciplinary research to study how compounds found in botanicals can suppress inflammation and identify new
pathways that trigger or prevent inflammation by providing state-of-the-art research facilities to investigators.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Advisory CommitteesAgingAreaAttenuatedAutoimmune DiseasesBasic ScienceBotanicalsBusinessesCardiovascular DiseasesCell SeparationCellsCenters of Research ExcellenceChronicClinicalCommunicable DiseasesComplementary and alternative medicineCore FacilityData AnalysesDiseaseEpigenetic ProcessEquipmentFacultyFinancial SupportFlow CytometryFundingGoalsGrantHypersensitivityImmunosuppressive AgentsIncomeIndividualInfectionInflammationInflammatoryInstitutionInterdisciplinary StudyInternationalLibrariesMalignant NeoplasmsMentorsMissionModalityMonitorNatural CompoundNatural ProductsNervous System DisorderNeurodegenerative DisordersObesityPathogenesisPathway interactionsPerformancePhasePilot ProjectsPlayPredispositionProductivityRegulationResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResearch SupportRoleScientistSecureSourceSouth CarolinaTechnologyToxic effectTrainingUnited States Department of Veterans AffairsUnited States National Institutes of HealthUniversitiesautoimmune pathogenesischronic inflammatory diseasecollegedietary supplementsdrug discoveryeffective therapyepigenetic regulationepigenomicsexpectationfaculty researchinnovationinterestmedical schoolsmembermicrobiomemultidisciplinarynovelpreventprogramsrecruitresearch facilitysingle cell analysissingle-cell RNA sequencingsuccesstenure tracktranscriptomics
No Sub Projects information available for 1P30GM154631-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1P30GM154631-01
Patents
No Patents information available for 1P30GM154631-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1P30GM154631-01
Clinical Studies
No Clinical Studies information available for 1P30GM154631-01
News and More
Related News Releases
No news release information available for 1P30GM154631-01
History
No Historical information available for 1P30GM154631-01
Similar Projects
No Similar Projects information available for 1P30GM154631-01